Generic Pharmaceutical Substitution Management

The contract involves the provision of FDA 'A' rated generic drugs to serve as therapeutically equivalent substitutes for brand-name pharmaceuticals. When substitution with a generic alternative is not feasible, the contractor is required to provide clinical justification to support such exceptions. This service aims to support the Department of Defense's Defense Health Agency by ensuring cost-effective medication management while maintaining clinical efficacy and safety. The subcontract is categorized under NAICS code 424210, which pertains to pharmaceutical preparation distribution. The place of performance is specified as San Antonio, with a postal code of 78230. The contract was announced on May 7, 2026, and responses are due by June 29, 2026. The effort focuses on optimizing pharmaceutical substitutions within the defense health system, aligning with the agency’s objectives to enhance healthcare delivery through effective and justified drug substitution practices.